We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$752M
AUM Growth
+$110M
Cap. Flow
+$81.1M
Cap. Flow %
10.79%
Top 10 Hldgs %
40.28%
Holding
184
New
49
Increased
34
Reduced
33
Closed
54

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$17.2M
2
ORCL icon
Oracle
ORCL
+$13.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$12.5M
4
NGD
New Gold Inc
NGD
+$10.2M
5
INCY icon
Incyte
INCY
+$9.49M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17.2M
2
SSNI
Silver Spring Networks, Inc.
SSNI
+$12.8M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BRG
Bluerock Residential Growth REIT, Inc.
BRG
+$8.05M
5
MKTX icon
MarketAxess Holdings
MKTX
+$7.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.31%
2 Technology 13.37%
3 Materials 7.6%
4 Utilities 6.6%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIVV
101
DELISTED
Bioverativ Inc. Common Stock
BIVV
$399K 0.05%
+7,000
New +$410K
LXU icon
102
LSB Industries
LXU
$824M
$397K 0.05%
+65,000
New +$389K
CRM icon
103
Salesforce
CRM
$154B
$374K 0.05%
4,000
-5,000
-56% -$460K
PWR icon
104
Quanta Services
PWR
$84.2B
$374K 0.05%
+10,000
New +$351K
ALDR
105
DELISTED
Alder Biopharmaceuticals
ALDR
$368K 0.05%
+30,000
New +$313K
XLNX
106
DELISTED
Xilinx Inc
XLNX
$354K 0.05%
+5,000
New +$327K
ATRC icon
107
AtriCure
ATRC
$2.08B
$336K 0.04%
15,000
– –
RGNX icon
108
Regenxbio
RGNX
$616M
$330K 0.04%
10,000
– –
MRK icon
109
Merck
MRK
$322B
$320K 0.04%
+5,240
New +$318K
SLCA
110
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$311K 0.04%
+10,000
New +$290K
NVTR
111
DELISTED
Nuvectra Corporation Common Stock
NVTR
$293K 0.04%
22,095
– –
PEGA icon
112
Pegasystems
PEGA
$5.09B
$288K 0.04%
+10,000
New +$289K
ALDX icon
113
Aldeyra Therapeutics
ALDX
$97.1M
$285K 0.04%
39,552
+25,000
+172% +$131K
AKCA
114
DELISTED
Akcea Therapeutics Inc
AKCA
$277K 0.04%
+10,000
New +$185K
DERM
115
DELISTED
Dermira, Inc.
DERM
$270K 0.04%
10,000
– –
CSTM icon
116
Constellium
CSTM
$3.76B
$256K 0.03%
+25,000
New +$237K
OXFD
117
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$252K 0.03%
15,000
-5,000
-25% -$81.4K
GRDX
118
GridAI Technologies Corp
GRDX
$18.3M
– –
0
– –
EA icon
119
Electronic Arts
EA
$52.4B
$236K 0.03%
+2,000
New +$232K
BOX icon
120
Box
BOX
$4.49B
$232K 0.03%
+12,000
New +$225K
CERS icon
121
Cerus
CERS
$575M
$218K 0.03%
80,000
– –
OPCH icon
122
Option Care Health
OPCH
$3.76B
$206K 0.03%
18,750
-212,500
-92% -$2.4M
VG
123
DELISTED
Vonage Holdings Corporation
VG
$204K 0.03%
+25,000
New +$188K
TLGT
124
DELISTED
Teligent, Inc
TLGT
$195K 0.03%
2,900
+400
+16% +$29.3K
CGRN
125
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$146K 0.02%
21,000
– –
3 4
5
6 7

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Ardsley Advisory Partners held 184 positions worth $752M, up 17% from $642M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ardsley Advisory Partners deployed $81.1M of net new capital in Q3 2017, opening 49 new positions and adding to 34 existing holdings. Its largest new stake was Centene: 400,000 shares worth $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Celgene Corp, an estimated $17.2M trimmed.

  • Ardsley Advisory Partners's largest Q3 2017 buy was Centene: 400,000 shares worth $19.4M.
  • Ardsley Advisory Partners added most to Zimmer Biomet in Q3 2017, an estimated $12.5M increase.
  • Ardsley Advisory Partners's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $17.2M.
  • Ardsley Advisory Partners fully exited Bluerock Residential Growth REIT, Inc. in Q3 2017, selling an estimated $8.05M.
  • Ardsley Advisory Partners's ten largest holdings make up 40% of its $752M portfolio in Q3 2017.
  • Ardsley Advisory Partners opened 49 new positions and closed 54 in Q3 2017.
  • Ardsley Advisory Partners's portfolio value rose 17% quarter-over-quarter to $752M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.